# Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method

> **NCT01986361** · PHASE3 · COMPLETED · sponsor: **Reckitt Benckiser LLC** · enrollment: 122 (actual)

## Conditions studied

- Acute Pharyngitis
- Sore Throat

## Interventions

- **DRUG:** flurbiprofen
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01986361
- **Lead sponsor:** Reckitt Benckiser LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2017-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986361, "Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01986361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*